Siga Technologies (SIGA) Shares Outstanding (Diluted Average) (2010 - 2025)
Siga Technologies (SIGA) reported Shares Outstanding (Diluted Average) of $71.6 million for Q3 2025, little changed on a YoY basis from $71.9 million in Q3 2024, and little changed quarter-over-quarter from $71.7 million in Q2 2025.
Siga Technologies (SIGA) Shares Outstanding (Diluted Average) (2010 - 2025) Analysis & Trends
Siga Technologies has reported Shares Outstanding (Diluted Average) for 16 years, with the latest figure at $71.6 million in Q3 2025.
- For the quarter ending Q3 2025, Shares Outstanding (Diluted Average) changed 0.35% year-over-year to $71.6 million; the trailing twelve-month figure through Sep 2025 stood at $71.6 million (changed 0.35% YoY), and the FY2024 full-year result was $71.9 million, changed 0.32% from the prior year.
- Shares Outstanding (Diluted Average) for Q3 2025 stood at $71.6 million, roughly flat from $71.7 million in the prior quarter.
- The five-year high for Shares Outstanding (Diluted Average) was $77.6 million in Q1 2021, with the low at $71.4 million in Q1 2025.
- Historically, Shares Outstanding (Diluted Average) has averaged $73.0 million across 5 years, with a median of $71.9 million in 2024.
- Annual changes were most pronounced in 2021 — Shares Outstanding (Diluted Average) slipped 6.51% — and 2024, when it rose 0.56%.
- Siga Technologies' Shares Outstanding (Diluted Average) stood at $76.4 million in 2021, then dropped by 3.74% to $73.5 million in 2022, then decreased by 2.54% to $71.7 million in 2023, then rose by 0.32% to $71.9 million in 2024, then declined by 0.42% to $71.6 million in 2025.
- The last three Shares Outstanding (Diluted Average) figures came in at $71.6 million (Q3 2025), $71.7 million (Q2 2025), and $71.4 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 1.18 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 422.40 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 47.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 103.40 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 506.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 228.36 Mn |
| 10 | Siga Technologies | 310.79 Mn | 155.83 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 71.60 Mn |
| Jun 30, 2025 | 71.75 Mn |
| Mar 31, 2025 | 71.43 Mn |
| Dec 31, 2024 | 71.91 Mn |
| Sep 30, 2024 | 71.85 Mn |
| Jun 30, 2024 | 71.75 Mn |
| Mar 31, 2024 | 71.56 Mn |
| Dec 31, 2023 | 71.68 Mn |
| Sep 30, 2023 | 71.45 Mn |
| Jun 30, 2023 | 71.64 Mn |
| Mar 31, 2023 | 72.20 Mn |
| Dec 31, 2022 | 73.55 Mn |
| Sep 30, 2022 | 73.26 Mn |
| Jun 30, 2022 | 73.33 Mn |
| Dec 31, 2021 | 76.40 Mn |
| Sep 30, 2021 | 74.84 Mn |
| Jun 30, 2021 | 76.66 Mn |
| Mar 31, 2021 | 77.57 Mn |
| Dec 31, 2020 | 79.44 Mn |
| Sep 30, 2020 | 80.05 Mn |